VGI Health Technology (XNEC:VTL) EBITDA Margin % : 0.00% (As of . 20)

View and export this data going back to 2021. Start your Free Trial

What is VGI Health Technology EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. VGI Health Technology's EBITDA for the six months ended in . 20 was A$0.00 Mil. VGI Health Technology's Revenue for the six months ended in . 20 was A$0.00 Mil. Therefore, VGI Health Technology's EBITDA margin for the quarter that ended in . 20 was 0.00%.

VGI Health Technology EBITDA Margin % Historical Data

The historical data trend for VGI Health Technology's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

VGI Health Technology EBITDA Margin % Chart

VGI Health Technology Annual Data

Trend

EBITDA Margin %

VGI Health Technology Semi-Annual Data

EBITDA Margin %

Competitive Comparison of VGI Health Technology's EBITDA Margin %

For the Biotechnology subindustry, VGI Health Technology's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

VGI Health Technology's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, VGI Health Technology's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where VGI Health Technology's EBITDA Margin % falls into.

VGI Health Technology EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

VGI Health Technology's EBITDA Margin % for the fiscal year that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (A: . 20 )	/	Revenue (A: . 20 )
	=		/
	=	%

VGI Health Technology's EBITDA Margin % for the quarter that ended in . 20 is calculated as

EBITDA Margin %	=	EBITDA (Q: . 20 )	/	Revenue (Q: . 20 )
	=		/
	=	%

VGI Health Technology (XNEC:VTL) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

VGI Health Technology EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of VGI Health Technology's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

VGI Health Technology (XNEC:VTL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » VGI Health Technology Ltd (XNEC:VTL) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

19 Martin Place, Level 45, Suite 03, Sydney, NSW, AUS, 2003

Website

https://www.vgiht.com

VGI Health Technology Ltd develops and commercializes evidence-based nutraceuticals and pharmaceuticals. It has two evidence-based nutraceutical products ready for commercial launch in the US as well as a therapeutic drug development program. The nE1-Heart targets maintenance of heart health - tocotrienols have a similar mode of action (inhibition of HMCG CoA biosynthesis) as statins, the Gold Standard for treatment of hyperlipidaemia; and nE1-Eliteth that reduces Delayed Onset Muscle Soreness, improves muscle recovery after exercise, exercise endurance and maintenance of peak muscle power.

VGI Health Technology (XNEC:VTL) Headlines

No Headlines